Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Arcus Biosciences, Inc.
GlaxoSmithKline
AstraZeneca
Poseida Therapeutics, Inc.
Genentech, Inc.
ImmunityBio, Inc.
Inhibrx Biosciences, Inc
HiFiBiO Therapeutics
HiFiBiO Therapeutics
BicycleTx Limited
Exelixis
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Cancer Research UK
Toray Industries, Inc
OncoC4, Inc.
Tempus AI
Cybrexa Therapeutics
Carisma Therapeutics Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Adaptimmune